Johnson & Johnson (JNJ): Intel Corporation (INTC)’s Gains Lead the Dow’s End-of-the-Week Rise

Page 1 of 2

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case they’re material to our investing thesis.

Markets are ending the week in a good way today, as stocks have moved higher to end a strong past five days on Wall Street. The Dow Jones Industrial Average has picked up gains of more than 60 points as of 2:15 p.m. EDT, with most of the stocks on the blue-chip index moving higher. Intel Corporation (NASDAQ:INTC) has had a big hand in the Dow’s outperformance, leading the index into the green. Let’s catch up on what you need to know.

Intel Corporation (NASDAQ:INTC)

Intel’s upgrade

Intel Corporation (NASDAQ:INTC) shares are up around 3% after Jefferies upgraded the chipmaker from “hold” to “buy.” An analyst at the company cited Intel’s production of less power-consuming chips, which will help the company expand its reach into mobile and other high-growth areas. Intel has had little success breaking into those new markets so far, with the exception of the server area, where it has established a strong hold.

Still, at least revenue from the company’s server products is growing. Intel Corporation (NASDAQ:INTC) has struggled financially lately, but the company’s data center division — its second-largest by revenue — posted 3.7% sales growth over the first half of 2013. Until Intel can bolster its product portfolio by becoming a real force in the mobile industry, data center sales will need to pick up the slack of slumping PC chip sales, which lost 7% in revenue in that same time frame.

That slump has hit the company’s net margin hard: In the second quarter of this year net margin fell to 15.6% from 20.9% a year ago. The stock has still managed to grow a respectable 13% year to date, but Intel Corporation (NASDAQ:INTC) will have to keep looking for new routes for growth if it wants to please shareholders and justify Jefferies’ upgrade.

Johnson & Johnson (NYSE:JNJ) is not keeping up with its Dow peers today. Shares of the diversified health-care giant are down 0.% to rank among the Dow’s biggest laggards. The company announced today that it will recall one lot of its schizophrenia therapy Risperdal Consta, although J&J was quick to mention that any possible patient risk was low.

Recalls are never a great sign for any health care firm, and Johnson & Johnson (NYSE:JNJ) has had its share of them over the past few years. Nonetheless, for investors, this company has performed admirably and looks on pace to continue its run into the future.

The company’s star immunology blockbuster, Remicade, continues to grow in sales despite already raking in more than $3.2 billion in revenue over the first half of the year. That was a 7.5% gain from the year before, and Remicade has formed a solid cash foundation for J&J to rely on while newer, faster-growing drugs, such as cancer treatment Zytiga, move up the ranks. Zytiga was approved only a few years ago, but the drug is already on pace to hit blockbuster status with more than $1 billion in sales by the end of the year — and Zytiga’s revenue jumped by more than 70% year over year in 2013′s first half.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

The 10 Biggest Outlet Malls in USA

The 5 Most Popular Rap Songs of All Time

The 10 Countries that Eat the Most Meat

The10 Most Expensive Countries to Fly To

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!